Holen Sie sich die Stockscreener-App
112.92
1.08%
-1.23
Schlusskurs vom Vortag:
$114.15
Offen:
$113.9
24-Stunden-Volumen:
553.62K
Relative Volume:
0.54
Marktkapitalisierung:
$6.49B
Einnahmen:
$360.35M
Nettoeinkommen (Verlust:
$-149.57M
KGV:
-38.15
EPS:
-2.96
Netto-Cashflow:
$-81.27M
1W Leistung:
+1.99%
1M Leistung:
+5.66%
6M Leistung:
+7.83%
1J Leistung:
-28.59%
1-Tages-Spanne:
$110.71
$114.77
1-Wochen-Bereich:
$109.07
$115.00
52-Wochen-Spanne:
$73.16
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Firmenname
Glaukos Corporation
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Vergleichen Sie GKOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
112.92 | 6.56B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Buy |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Can Glaukos Corporation stock deliver sustainable ROEWeekly Profit Recap & High Conviction Buy Zone Picks - ulpravda.ru
Why Glaukos Corporation stock is listed among top recommendations - ulpravda.ru
How Glaukos Corporation stock compares to industry benchmarksMarket Movement Recap & Daily Profit Maximizing Tips - ulpravda.ru
Why Glaukos Corporation stock could be top winnerEntry Point & Reliable Intraday Trade Alerts - ulpravda.ru
Will Glaukos Corporation stock deliver consistent dividendsJuly 2025 PreEarnings & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Issuer of GKOS (GKOS) common stock files Rule 144 sale notice - Stock Titan
Technical Analysis: Is Glaukos Corporation stock supported by strong fundamentalsJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - ulpravda.ru
Is Glaukos Corporation stock supported by strong fundamentalsMarket Performance Report & Weekly Top Performers Watchlists - ulpravda.ru
Can Glaukos Corporation stock resist market sell offsTrend Reversal & Safe Entry Zone Tips - ulpravda.ru
Analysis Recap: Why Glaukos Corporation stock is listed among top recommendationsAnalyst Upgrade & Safe Swing Trade Setup Alerts - ulpravda.ru
Market Review: How geopolitical risks impact Glaukos Corporation (6GJ) stock2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
Glaukos (GKOS) director Hoffmeister granted 753 restricted stock units - Stock Titan
Glaukos (GKOS) director Marc Stapley receives 727 restricted stock units - Stock Titan
Glaukos (GKOS) director Kliman reports 623 restricted stock units granted - Stock Titan
Is Glaukos Corporation stock positioned for digital transformationMarket Sentiment Indicators & Double Digit Returns - ulpravda.ru
Published on: 2026-01-07 21:02:26 - ulpravda.ru
Glaukos Corporation's (NYSE:GKOS) Shift From Loss To Profit - simplywall.st
FDA accepts Glaukos application for Epioxa for keratoconus - MSN
Glaukos approved for $14M Alabama tax credit - Lagniappe Daily
Block Trades: How geopolitical risks impact Glaukos Corporation 6GJ stockWeekly Profit Report & Capital Efficient Trade Techniques - moha.gov.vn
Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Allspring Global Investments Holdings LLC Sells 13,317 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Glaukos Corporation (NYSE:GKOS): Are Analysts Optimistic? - Yahoo Finance
Glaukos price target raised to $145 from $115 at Stephens - Yahoo Finance
Stephens & Co. Raises Glaukos (GKOS) Price Target to $145, Maint - GuruFocus
Glaukos (NYSE:GKOS) Given Buy Rating at BTIG Research - MarketBeat
Glaukos stock maintains Buy rating at BTIG on Epioxa launch potential - Investing.com
Glaukos (GKOS) Receives Continued "Buy" Rating from BTIG Analyst | GKOS Stock News - GuruFocus
Glaukos stock maintains Buy rating at BTIG on Epioxa launch potential By Investing.com - Investing.com Nigeria
Glaukos (NYSE: GKOS) insider details RSU tax withholding on Form 4 - Stock Titan
Glaukos (NYSE: GKOS) CEO discloses tax-withholding share transaction - Stock Titan
Avoiding Lag: Real-Time Signals in (GKOS) Movement - Stock Traders Daily
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Harbor Capital Advisors Inc. Decreases Stake in Glaukos Corporation $GKOS - MarketBeat
Glaukos price target raised to $125 from $113 at Citi - MSN
Glaukos Corp (NYSE:GKOS) Shares Rise After Quarterly Results - Kalkine Media
Glaukos Corporation $GKOS Shares Purchased by Voya Investment Management LLC - MarketBeat
UBS Maintains Glaukos (GKOS) Buy Recommendation - Nasdaq
J.P. Morgan Healthcare Conference - marketscreener.com
Glaukos Corporation $GKOS Shares Purchased by Riverbridge Partners LLC - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Why Glaukos Corporation (6GJ) stock is listed among top recommendations2025 Fundamental Recap & Target Return Focused Picks - Улправда
EBIT per share of Glaukos Corp – DUS:6GJ - TradingView — Track All Markets
Assenagon Asset Management S.A. Has $12.85 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat
Technical Reactions to GKOS Trends in Macro Strategies - Stock Traders Daily
Will Glaukos Corporation stock gain from government policiesJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - ulpravda.ru
What valuation multiples suggest for Glaukos Corporation stockJuly 2025 Spike Watch & Daily Stock Trend Reports - Улправда
How Glaukos Corporation stock benefits from strong dollar2025 Growth vs Value & Weekly High Conviction Ideas - DonanımHaber
Will Glaukos Corporation stock outperform growth indexesJuly 2025 Trade Ideas & Weekly High Return Forecasts - Улправда
Market Overview: Is Glaukos Corporation stock positioned for digital transformationPortfolio Risk Report & Low Risk Profit Maximizing Plans - Улправда
Finanzdaten der Glaukos Corporation-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Glaukos Corporation-Aktie (GKOS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kliman Gilbert H | Director |
Dec 09 '25 |
Option Exercise |
24.69 |
5,000 |
123,450 |
39,905 |
| Kliman Gilbert H | Director |
Dec 09 '25 |
Sale |
107.27 |
5,000 |
536,350 |
34,905 |
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):